Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.230
-0.020 (-0.89%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Neumora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 411 | 304 | 1,713 | 2,604 | - | - | |
| Market Cap Growth | 272.73% | -82.24% | -34.22% | - | - | - | |
| Enterprise Value | 284 | 153 | 1,374 | 2,090 | - | - | |
| Last Close Price | 2.25 | 1.79 | 10.60 | 17.05 | - | - | |
| PB Ratio | 3.77 | 2.93 | 5.97 | 5.55 | - | - | |
| P/TBV Ratio | 3.96 | 2.93 | 5.97 | 5.55 | - | - | |
| Debt / Equity Ratio | 0.53 | 0.53 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Net Debt / Equity Ratio | -1.23 | -1.23 | -1.06 | -0.98 | -0.97 | -1.01 | |
| Net Debt / EBITDA Ratio | 0.54 | 0.54 | 1.16 | 2.45 | 3.17 | 5.10 | |
| Net Debt / FCF Ratio | 0.62 | 0.62 | 1.66 | 2.73 | 3.01 | 5.34 | |
| Quick Ratio | 5.63 | 5.63 | 10.29 | 18.08 | 15.73 | 17.59 | |
| Current Ratio | 5.87 | 5.87 | 10.51 | 19.05 | 16.37 | 17.85 | |
| Return on Equity (ROE) | -121.21% | -121.21% | -64.48% | -54.49% | -32.67% | -80.18% | |
| Return on Assets (ROA) | -58.11% | -58.11% | -40.50% | -25.50% | -17.95% | -16.01% | |
| Return on Capital Employed (ROCE) | -148.90% | -148.90% | -91.80% | -39.90% | -30.50% | -19.80% | |
| Earnings Yield | -57.64% | -77.89% | -14.24% | -9.06% | - | - | |
| FCF Yield | -50.22% | -67.87% | -10.73% | -6.45% | - | - | |
| Buyback Yield / Dilution | -2.52% | -2.52% | -145.12% | -138.99% | -24.25% | -68.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.